Clinical trial registry record

Effects of Compound Probiotics-Polygonatum Sibiricum on Liver Health and Metabolism in Middle-aged and Elderly People

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Not Yet Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated March 12, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06873412
Last registry update
March 12, 2025
Status
Not Yet Recruiting
Phase
Phase not reported
Sponsor
Wecare Probiotics Co., Ltd.
Enrollment
84
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · TREATMENT · SINGLE
Evidence population
Human clinical study registration
Participants
84
Population
ALL · 40 Years to 80 Years
Duration
2025-03-10 to 2026-12-01
Intervention
Probiotic; Placbo
Comparator
Probiotic group; Placebo group
Outcomes measured
Changes in alanine aminotransferase (ALT) levels — 3 months; Changes in aspartate aminotransferase (AST) levels — 3 months; Changes in basal metabolic rate — 3 months; Metabolic index — 3 months; Gamma-glutamyltransferase (GGT) — 3 months; Total bilirubin (TBil) — 3 months; Uric acid — 3 months; Weight — 3 months; BMI (body mass index) — 3 months; Fasting blood glucose — 3 months; Total cholesterol — 3 months; Triglyceride — 3 months; Low-density lipoprotein (LDL) — 3 months; High density lipoprotein (HDL) — 3 months; Changes in malondialdehyde (MDA) levels — 3 months; Changes in the level of superoxide dismutase (SOD) — 3 months; Changes in glutathione (GSH) levels — 3 months; Fatigue Severity Scale (FSS) — 3 months; Pittsburgh Sleep Quality Index (PSQI) — 3 months; Short-chain fatty acids (SCFAs) — 3 months
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Probiotics and prebiotics · 100%Title contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

probiotics prebiotics aging
Read the original source →Export JSON